Fluctuations in pain intensity are a core feature of non-specific chronic low back pain (nsCLBP), yet most mechanistic studies do not explicitly account for within-person pain-state variability. The study aimed to develop and implement a protocol that systematically assesses how differing pain states influence multimodal pain-related measures. The investigators tested the feasibility of a pain state–dependent pseudorandomized design in a clinical sample and compared findings to healthy controls.
The final study cohort included 45 patients with nsCLBP and 47 age- and sex-matched healthy controls (HCs). Patients were scheduled for three separate visits, each intended to capture a different pain state: a clinically relevant pain state, a low-intensity clinical pain or pain-free state, and a clinically irrelevant pain state induced experimentally. Healthy controls attended a single visit for cross-sectional comparison. The clinical trial registration identifier was reported as NCT06412484.
Patients monitored pain fluctuations via online self-reports every four days. Those frequent assessments were used to guide a pseudorandomized scheduling algorithm so that each patient’s three visits would occur during the target pain states when possible. The design accounted for the inherent uncertainty of pain-state transitions by relying on repeated self-report to capture state changes in near–real time.
Each study visit comprised a multimodal battery of pain-related measures. The manuscript describes the structure and implementation of these multimodal assessments across visits but does not provide detailed lists of every measurement in the abstract. One experimentally induced pain state used a Qutenza 8% capsaicin patch to create a clinically irrelevant pain condition of moderate-to-high intensity across assessments.
Self-report adherence was high, supporting the scheduling approach: the median self-report adherence was 93.48%. The authors reported no relationship between adherence and perceived self-report burden (Spearman rho = -0.097, p = 0.53). Visit completion was high: 93.33% of patients completed all three visit types in a pseudorandomized order. A chi-squared test for completion patterns was reported (chi-squared = 1.50, p = 0.826), indicating no significant deviation in order distribution.
Visited states differed as intended. The mean (SD) low back pain intensity during the clinically relevant pain visit was 3.98 (0.90), compared with 1.03 (0.86) during the low-intensity clinical pain visit and 1.13 (0.82) during the clinically irrelevant pain visit; those differences were statistically significant (p-values < 0.001). The use of the Qutenza 8% capsaicin patch successfully induced a moderate-to-high clinically irrelevant pain across assessments, supporting its utility for producing a controlled pain state within the protocol.
Ethical approval for the study was granted by the Ethics committee of Kantonale Ethikkommission Zurich. The authors declared that all relevant ethical guidelines were followed and that participant consent was obtained. The study reports funding from the University of Zurich and the Swiss National Science Foundation. The authors declared no competing interests. Data produced in the study are available on reasonable request to the authors.
The authors conclude that a pain state–dependent pseudorandomized design is feasible for studying nsCLBP despite the logistical complexity introduced by scheduling and uncertainty in pain-state transitions. High adherence to frequent self-reports made state-informed scheduling possible. The protocol demonstrated that clinically distinct states and an experimentally induced clinically irrelevant pain state can be captured reliably within this framework. The study suggests that incorporating pain-state variability into mechanistic investigations could improve understanding of nsCLBP, though the abstract does not report specific mechanistic outcomes or detailed multimodal results beyond feasibility metrics.